After five to ten years on levodopa, the gold-standard drug for Parkinson’s disease, up to 80 percent of patients develop a cruel trade-off: the medication that restores their ability to move also ...

Summary: Researchers developed CapuchinAI, an open-source, battery-powered platform that automates cognitive studies of wild primates using facial recognition and touchscreen interaction. Field-tested ...